FDA Approval of Pimavanserin: Response to Absence of Evidence Versus Evidence of Absence-Pimavanserin and the SAPS-PD.

FDA Approval of Pimavanserin: Response to Absence of Evidence Versus Evidence of Absence-Pimavanserin and the SAPS-PD.
Am J Geriatr Psychiatry. 2018 Jul 07;:
Authors: Schubmehl S, Sussman J
PMID: 30100268 [PubMed - as supplied by publisher]

Source: The American Journal of Geriatric Psychiatry - August 14, 2018 Category: Psychiatry Tags: Am J Geriatr Psychiatry Source Type: research